Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Lipidem 20% vs Lipofundin in Preterm Infants
NCT00497289Phase 2Completed
- Sponsor
- B. Braun
- Start
- Jan 2006
- Primary completion
- Feb 2008
- Modality
- Nanoparticles
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial of Lipidem in Prematurity (PTB) (2 arms), sponsored by B. Braun. Primary endpoints: Alanine Transaminase at Day 6 and Interleukin-6 at Day 6. Started Jan 2006; status: completed.
02
Drugs
Lipidem
03
Conditions
Prematurity (PTB)
Beyond the preview
Go deeper on NCT00497289.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00497289.